Pfizer, the world’s largest drugmaker, last week warned doctors about the increased risk of hyperglycemia and diabetes in patients taking its antipsychotic drug Geodon.
The U.S. Food and Drug Administration requested that a warning be added to the prescribing information for all so-called atypical anti-psychotics regarding the risk of hyperglycemia and diabetes, Pfizer said.
Pfizer, in the […]

The U.S. Food and Drug Administration has asked the makers of six atypical antipsychotic drugs to update product labeling to include a warning about a possible link with diabetes, The Associated Press reported. The atypical antipsychotic drugs includes Zyprexa by Eli Lilly & Co., Clozaril by Novartis, Risperdal by Janssen, Seroquel by AstraZeneca, Geodon by […]